Treprostinil controlled release (Camurus) | Interleukin Related interleukin-related.com

Product Name :
Treprostinil controlled release (Camurus)

Search keywords :
Treprostinil

drugId :
null

Target Vo:
Prostanoid IP receptor

Target Vo Short Name :
PTGIR

Moa_Name:
Prostanoid IP receptor agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Camurus Ab

Active Company_Name :
Camurus Ab

Active Indication_Name:
Raynaud Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FMRP Antibody
xCT Antibody (YA652)
NDRG1 Antibody: NDRG1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to NDRG1. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts